Teva Ashdod workers' demonstration  photo: Histadrut Court allows closure of Teva's Ashdod plant

The Beersheva District Court rejected the Histadrut's claim that Teva had acted in bad faith.

Ron Hadassi  photo: Eyal Izhar Elbit Imaging to sell shares in Elbit Medical

Elbit Imaging has agreed to sell up to 50% of Elbit Medical to Exigent Capital at a 6% discount.

Yaki Zinger  photo: Shmuel Adler LR raising $130m to invest in Jerusalem med cos

The LR Group won a tender by the Ministry of Jerusalem Affairs and Heritage and the Jerusalem municipality.

David Golan and Chris Mansi Photo: AI healthcare co raises $21m uses artificial intelligence to analyze CT scans in order to help doctors diagnose and treat strokes.

Prof. Steven Lamm Photo: Eyal Izhar "Sleep is as important as food and water"

Prof. Steven Lamm, in Israel as a consultant to Itamar Medical, tells "Globes" that sleep is more important than physical exercise.

Digital health Photo: Shutterstock Personal health data co K Health raises $12.5m

The company also announced the launch of K, a free, first-of-its-kind primary care app along with a new provider network available in New York.

Ami Appelbaum Photo: Eyal Yitzhar Innovation Authority grants NIS 120m to 3 int'l med-tech cos

Medtronic and GE Healthcare will receive NIS 50 million each and Change Healthcare will get NIS 20 million to expand Israel operations.

Cannabis Together to begin Canadian medical cannabis sales in Jan

The company has ordered cannabis plant seeds from a Dutch supplier for its farm, which the company is setting up in Uganda.

 Ayelet Dilion-Mashiah Photo: PR Israeli chemotherapy co NewStem raises $4m

NewStem’s technology can predict patients’ resistance to chemotherapy allowing for better, targeted cancer treatments and the potential to reduce resistance to chemotherapy.

Michel Vounatsos  photo: PR Biogen looks to pharma-tech interface

Biogen CEO Michel Vounatsos seeks synergy between pharma and technology, and found kindred spirits in Israel.

Copaxone Mylan generic Copaxone price cut puzzles industry

Mylan is changing its strategy after failing to take market share away from Teva.

Exit Photo: Thinkstock Israeli tech exits: 2 mega deals but basic trend down

Excluding Orbotech and NDS, the average exit deal in the first half of 2018 was down nearly 50% compared with 2015 and 2016.

Dead Sea picture: Tamar Mitzpi Together teams with cosmetics co Premier Dead Sea

The two companies will form a joint company in Europe to produce CBD-based cosmetics .

Sharon Dvir, Boaz Wachtel Photo: Jonathan Bloom Cannabis agreement boosts Roots on ASX

Israeli company Canndoc will test Roots' technology on cannabis crops.

Cannabis Former Teva Israel CEO founds crowdfunded cannabis co

Ron Mayron announced the founding of InnoCan Pharma, which plans to raise money through the Pipelbiz platform.

Medical cannabis Photo: Shutterstock Israel's cannabis market shrouded in uncertainty

Restrictions on foreign investors and the government's reluctance to approve exports are inhibiting growth in Israel's medical cannabis sector.

Lior Shalev Photo: Shlomi Yosef Impact investment blends business and social aims

Lior Shalev, grandson of Teva founder Eli Hurvitz, targets the 'double bottom line' - both economic and social profit.

Kare Schultz Photo: PR Teva well on the road to recovery

The company's share price has risen 118% since Kare Schultz became CEO in November, and 23.5% in the past month. What has changed?

Dr. Ilan Samish Photo: PR Israeli co offers sweet protein as sugar substitute

Amai Proteins designs sweet proteins that do not affect the sugar levels in the blood.

Eyal Ballan, Eyal Barad, Noam Permont  photo: Eyal Izhar Targeting cancer with cannabis

Cannabics seeks to match cannabis compounds to treatment of specific tumors.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018